The CB1 receptor as an important mediator of hedonic reward processing

Neuropsychopharmacology

Volumn 39, Issue 10, 2014, Pages 2387-2396

  Friemel, Chris M ^a   Zimmer, Andreas ^b   Schneider, Miriam ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; RIMONABANT; TRANSCRIPTION FACTOR FOSB; BENZOXAZINE DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; FOSB PROTEIN, MOUSE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PROTEIN C FOS;

ACOUSTIC REFLEX; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REWARD; SMELLING; STARTLE REFLEX; STRIATE CORTEX; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; ASSOCIATION; CONDITIONING; CORPUS STRIATUM; DRUG EFFECTS; GENETICS; HEARING; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; STIMULATION; WISTAR RAT;

ANIMALS; AUDITORY PERCEPTION; BENZOXAZINES; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; CONDITIONING (PSYCHOLOGY); CORPUS STRIATUM; CUES; MALE; MICE, KNOCKOUT; MORPHOLINES; NAPHTHALENES; OLFACTORY PERCEPTION; PHYSICAL STIMULATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REFLEX, STARTLE; REWARD;

EID: 84906312769     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.86     Document Type: Article

References (55)

1. Ameri A (1999). The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348
2. Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS (2001). The distribution of cannabinoid-induced Fos expression in rat brain: Differences between the Lewis and Wistar strain. Brain Res 921: 240-255
3. Arnone M, Maruani J, Chaperon F, Thiebot M, Poncelet M, Soubrie P et al (1997). Selective inhibition of sucrose and ethanol intake by SR 1411716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132: 104-106
4. Barbano MF, Cador M (2007). Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology 191: 497-506
5. Berridge KC, Kringelbach ML (2008). Affective neuroscience of pleasure: Reward in humans and animals. Psychopharmacology 199: 457-480
6. Brand T, Spanagel R, Schneider M (2012). Decreased reward sensitivity in rats from the Fischer344 strain compared to Wistar rats is paralleled by differences in endocannabinoid signaling. PLoS One 7: E31169
7. Chao J, Nestler EJ (2004). Molecular neurobiology of drug addiction. Annu Rev Med 55: 113-132
8. Chaperon F, Thiebot M (1999). Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13: 243-281
9. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M et al (2003). The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423-431
10. Cota D, Tschop MH, Horvath TL, Levine AS (2006). Cannabinoids, opioids and eating behavior: The molecular face of hedonism? Brain Res Rev 51: 85-107
11. Darmani NA, Pandya DK (2000). Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. J Neural Transm 107: 931-945
12. Davis M (1998). Anatomic and physiologic substrates of emotion in an animal model. J Clin Neurophysiol 15: 378-387
13. Davis M, Walker DL, Myers KM (2003). Role of the amygdala in fear extinction measured with potentiated startle. Ann NY Acad Sci 985: 218-232
14. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z et al (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825
15. Egertova M, Cravatt BF, Elphick MR (2003). Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: Evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119: 481-496
16. El Rawas R, Klement S, Salti A, Fritz M, Dechant G, Saria A et al (2012). Preventive role of social interaction for cocaine conditioned place preference: Correlation with FosB/DeltaFosB and pCREB expression in rat mesocorticolimbic areas. Front Behav Neurosci 6: 8
17. Elphick MR (2012). The evolution and comparative neurobiology of endocannabinoid signalling. Philos Trans R Soc Lond Ser B 367: 3201-3215
18. Enkel T, Spanagel R, Vollmayr B, Schneider M (2010). Stress triggers anhedonia in rats bred for learned helplessness. Behav Brain Res 209: 183-186
19. Esch T, Stefano GB (2004). The neurobiology of pleasure, reward processes, addiction and their health implications. Neuro Endocrinol Lett 25: 235-251
20. Fattore L, Melis M, Fadda P, Pistis M, Fratta W (2010). The endocannabinoid system and nondrug rewarding behaviours. Exp Neurol 224: 23-36
21. Friemel CM, Spanagel R, Schneider M (2010). Reward sensitivity for a palatable food reward peaks during pubertal development in rats. Front Behav Neurosci 4: 39
22. Herkenham M, Lynn AB, de Costa BR, Richfield EK (1991). Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 547: 267-274
23. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936
24. Holter SM, Kallnik M, Wurst W, Marsicano G, Lutz B, Wotjak CT (2005). Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task. Eur J Pharmacol 510: 69-74
25. Järbe TU, Andrzejewski ME, DiPatrizio NV (2002). Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: Open-field revisited. Pharmacol Biochem Behav 73: 911-919
26. Jarrett MM, Scantlebury J, Parker LA (2006). Effect of Delta(9)-Tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 90: 425-430
27. Jarrett MM, Scantlebury J, Parker LA (2007). Effect of Delta(9)-Tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 90: 425-430
28. Kirkham TC (2009). Cannabinoids and appetite: Food craving and food pleasure. Int Rev Psychiatry 21: 163-171
29. Koch M, Schmid A, Schnitzler HU (1996). Pleasure-Attenuation of startle is disrupted by lesions of the nucleus accumbens. NeuroReport 7: 1442-1446
30. Koch M, Schmid A, Schnitzler HU (2000). Role of the nucleus accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacology 152: 67-73
31. Kringelbach ML, Berridge KC (2009). Towards a functional neuroanatomy of pleasure and happiness. Trends Cogn Sci 13: 479-487
32. Lang PJ (1995). The emotion probe. Studies of motivation and attention. Am Psychol 50: 372-385
33. Lang PJ, Bradley MM, Cuthbert BN (1990). Emotion, attention, and the startle reflex. Psychol Rev 97: 377-395
34. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F et al (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (New York, NY) 283: 401-404
35. Lopez-Moreno JA, Lopez-Jimenez A, Gorriti MA, de Fonseca FR (2010). Functional interactions between endogenous cannabinoid and opioid systems: Focus on alcohol, genetics and drugaddicted behaviors. Curr Drug Targets 11: 406-428
36. Mahler SV, Smith KS, Berridge KC (2007). Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 32: 2267-2278
37. Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA (1999). Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20: 287-294
38. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG et al (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534
39. McLaughlin PJ, Winston KM, Limebeer CL, Parker LA, Makriyannis A, Salamone JD (2005). The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology (Berl) 180: 286-293
40. Norrholm SD, Jovanovic T, Vervliet B, Myers KM, Davis M, Rothbaum BO et al (2006). Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learn Mem 13: 681-685
41. Parolaro D, Rubino T, Vigano D, Massi P, Guidali C, Realini N (2010). Cellular mechanisms underlying the interaction between cannabinoid and opioid system. Curr Drug Targets 11: 393-405
42. Paxinos G, Franklin KBJ (2001). The Mouse Brain in Stereotaxic Coordinates. 2nd edn Academic Press: San Diego, CA
43. Poncelet M, Maruani J, Calassi R, Soubrie P (2003). Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343: 216-218
44. Salamone JD, Correa M, Farrar A, Mingote SM (2007). Effortrelated functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191: 461-482
45. Sanchis-Segura C, Cline BH, Marsicano G, Lutz B, Spanagel R (2004). Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology (Berl) 176: 223-232
46. Schmid A, Koch M, Schnitzler HU (1995). Conditioned pleasure attenuates the startle response in rats. Neurobiol Learn Mem 64: 1-3
47. Schneider CA, Rasband WS, Eliceiri KW (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675
48. Schneider M, Heise V, Spanagel R (2010). Differential involvement of the opioid receptor antagonist naloxone in motivational and hedonic aspects of reward. Behav Brain Res 208: 466-472
49. Schneider M, Koch M (2002). The cannabinoid agonist WIN 55, 212-2 reduces sensorimotor gating and recognition memory in rats. Behav Pharmacol 13: 29-37
50. Schneider M, Spanagel R (2008). Appetitive odor-cue conditioning attenuates the acoustic startle response in rats. Behav Brain Res 189: 226-230
51. Schultz W (2010). Dopamine signals for reward value and risk: Basic and recent data. Behav Brain Funct 6: 24
52. Solinas M, Goldberg SR, Piomelli D (2008). The endocannabinoid system in brain reward processes. Br J Pharmacol 154: 369-383
53. Soria G, Mendizabal V, Tourino C, Robledo P, Ledent C, Parmentier M et al (2005). Lack of CB1 cannabinoid receptor impairs cocaine self-Administration. Neuropsychopharmacology 30: 1670-1680
54. Vrana SR, Spence EL, Lang PJ (1988). The startle probe response: A new measure of emotion? J Abnorm Psychol 97: 487-491
55. Zimmer A, Zimmer AM, Hohman AG, Herkenham M, Bonner TI (1999). Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96: 5780-5785